Renaissance Capital logo

Zogenix , Nasdaq: ZGNX

Recently launched Sumavel DosePro, a needle-free injectable migraine treatment.

Industry: Health Care

First Day Return: -0.5%

Industry: Health Care

Recently launched Sumavel DosePro, a needle-free injectable migraine treatment.
more less

Zogenix (ZGNX) Performance